表紙:世界の末梢血単核細胞 (PBMC) の市場予測・競合動向・成長機会 (~2025年):製品・用途・技術・原料・地域別
市場調査レポート
商品コード
974941

世界の末梢血単核細胞 (PBMC) の市場予測・競合動向・成長機会 (~2025年):製品・用途・技術・原料・地域別

Global Peripheral Blood Mononuclear Cells Market, By Product, By Application, By Technique, By Source, By Region, Competition, Forecast & Opportunities, 2025

出版日: | 発行: TechSci Research | ページ情報: 英文 168 Pages | 納期: お問合せ

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.07円

こちらのレポートには、数時間(ご購入金額の10%)分のアナリストへの質問/追加調査サービスが含まれております。

世界の末梢血単核細胞 (PBMC) の市場予測・競合動向・成長機会 (~2025年):製品・用途・技術・原料・地域別
出版日: 2020年12月01日
発行: TechSci Research
ページ情報: 英文 168 Pages
納期: お問合せ
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の末梢血単核細胞 (PBMC) の市場規模は2019年の1億7229万米ドルから、予測期間中は8.46%のCAGRで堅調に推移すると予測されています。PBMCは臨床研究だけでなく、生物学や病理学関連の研究を実施するために不可欠な要素であり、また、致死性疾患、免疫学、ワクチン開発などの研究にも利用されています。一方で、PBMC関連の研究の高コスト性が特に新興諸国において、さらなる技術導入の障壁となる可能性があります。

当レポートでは、世界の末梢血単核細胞 (PBMC) の市場を調査し、市場の定義と概要、新型コロナウイルス感染症 (COVID-19) およびその他の市場影響因子の分析、世界および地域・国別の市場規模および市場シェアの推移・予測、製品・用途・技術・原料など各種区分別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

第1章 製品概要

第2章 調査手法

第3章 COVID-19の影響

第4章 エグゼクティブサマリー

第5章 顧客の声

第6章 世界市場の展望

  • 市場規模・予測
  • 市場シェア・予測
  • 製品別
    • 凍結保存または凍結PBMC
    • 培養または新鮮なPBMC
    • 末梢血単核細胞分離・生存率測定キット
  • 用途別
    • 免疫学
    • 感染症
    • 血液学など
  • 技術別
    • 密度勾配遠心分離プロセス
    • 白血球アフェレーシス
  • 原料別
    • 人間
    • 動物
  • 企業別
  • 地域別
  • 製品市場マップ

第7章 アジア太平洋市場の展望

  • 市場規模・予測
  • 市場シェア・予測
  • 製品別
  • 用途別
  • 技術別
  • 原料別
  • 国別

第8章 欧州市場の展望

  • 市場規模・予測
  • 市場シェア・予測
  • 製品別
  • 用途別
  • 技術別
  • 原料別
  • 国別

第9章 北米市場の展望

  • 市場規模・予測
  • 市場シェア・予測
  • 製品別
  • 用途別
  • 技術別
  • 原料別
  • 国別

第10章 南米市場の展望

  • 市場規模・予測
  • 市場シェア・予測
  • 製品別
  • 用途別
  • 技術別
  • 原料別
  • 国別

第11章 中東・アフリカ市場の展望

  • 市場規模・予測
  • 市場シェア・予測
  • 製品別
  • 用途別
  • 技術別
  • 原料別
  • 国別

第12章 市場力学

  • 促進要因
  • 課題

第13章 市場動向

第14章 臨床試験

第15章 競合情勢

  • 競合の見通し
  • 企業プロファイル
    • Thermo Fisher Scientific Inc.
    • Merck & Co., Inc.
    • Corning Incorporate
    • Bio-Rad Laboratories, Inc.
    • Cellero, LLC
    • Life Technologies (India) Pvt. Ltd.
    • Cell Applications, Inc.
    • DAPCEL, Inc.
    • Creative Bioarray
    • iXCells Biotechnologies USA, LLC
    • Miltenyi Biotec B.V. & CO. KG
    • STEMCELL Technologies Inc.
    • Precision Medicine Group, LLC.
    • StemExpress, LLC
    • HemaCare Corporation
    • BioVision, Inc.
    • BioLegend, Inc.
    • BioIVT LLC
    • Biopredic International
    • Zen-Bio Inc.

第16章戦略的提言

第17章 当社について・免責事項

図表

List of Figures

  • Figure 1: Global Peripheral Blood Mononuclear Cells Market Size, By Value, 2015-2025F (USD Million)
  • Figure 2: Global Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2015-2025F
  • Figure 3: Global Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2015-2025F
  • Figure 4: Global Peripheral Blood Mononuclear Cells Market Share, By Technique, By Value, 2015-2025F
  • Figure 5: Global Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2015-2025F
  • Figure 6: Global Peripheral Blood Mononuclear Cells Market Share, By Company, By Value, 2019
  • Figure 7: Global Peripheral Blood Mononuclear Cells Market Share, By Region, By Value, 2019 & 2025F
  • Figure 8: Global Peripheral Blood Mononuclear Cells Market Map, By Product - Market Size (USD Million) & Growth Rate (%)
  • Figure 9: Global Peripheral Blood Mononuclear Cells Market Map, By Application - Market Size (USD Million) & Growth Rate (%)
  • Figure 10: Global Peripheral Blood Mononuclear Cells Market Map, By Technique - Market Size (USD Million) & Growth Rate (%)
  • Figure 11: Global Peripheral Blood Mononuclear Cells Market Map, By Source - Market Size (USD Million) & Growth Rate (%)
  • Figure 12: Global Peripheral Blood Mononuclear Cells Market Map, By Region - Market Size (USD Million) & Growth Rate (%)
  • Figure 13: North America Peripheral Blood Mononuclear Cells Market Size, By Value, 2015-2025F (USD Million)
  • Figure 14: North America Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2015-2025F
  • Figure 15: North America Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2015-2025F
  • Figure 16: North America Peripheral Blood Mononuclear Cells Market Share, By Technique, By Value, 2015-2025F
  • Figure 17: North America Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2015-2025F
  • Figure 18: North America Peripheral Blood Mononuclear Cells Market Size, By Country, 2015-2025F
  • Figure 19: United States Peripheral Blood Mononuclear Cells Market Size, By Value, 2015-2025F (USD Million)
  • Figure 20: New Cancer Cases in United States, (%), 2019
  • Figure 21: United States Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2015-2025F
  • Figure 22: United States Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2015-2025F
  • Figure 23: United States Peripheral Blood Mononuclear Cells Market Share, By Technique, By Value, 2015-2025F
  • Figure 24: United States Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2015-2025F
  • Figure 25: Canada Peripheral Blood Mononuclear Cells Market Size, By Value, 2015-2025F (USD Million)
  • Figure 26: Canada Hospital Establishments, By Region, 2019 (Units)
  • Figure 27: Canada Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2015-2025F
  • Figure 28: Canada Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2015-2025F
  • Figure 29: Canada Peripheral Blood Mononuclear Cells Market Share, By Technique, By Value, 2015-2025F
  • Figure 30: Canada Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2015-2025F
  • Figure 31: Mexico Peripheral Blood Mononuclear Cells Market Size, By Value, 2015-2025F (USD Million)
  • Figure 32: Mexico Healthcare Spending, By Value, 2015 -2019 (USD Per Capita)
  • Figure 33: Mexico Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2015-2025F
  • Figure 34: Mexico Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2015-2025F
  • Figure 35: Mexico Peripheral Blood Mononuclear Cells Market Share, By Technique, By Value, 2015-2025F
  • Figure 36: Mexico Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2015-2025F
  • Figure 37: Europe Peripheral Blood Mononuclear Cells Market Size, By Value, 2015-2025F (USD Million)
  • Figure 38: Europe Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2015-2025F
  • Figure 39: Europe Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2015-2025F
  • Figure 40: Europe Peripheral Blood Mononuclear Cells Market Share, By Technique, By Value, 2015-2025F
  • Figure 41: Europe Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2015-2025F
  • Figure 42: Europe Peripheral Blood Mononuclear Cells Market Size, By Country, 2015-2025F
  • Figure 43: Germany Peripheral Blood Mononuclear Cells Market Size, By Value, 2015-2025F (USD Million)
  • Figure 44: New Cancer Cases in Germany, (%), 2019
  • Figure 45: Germany Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2015-2025F
  • Figure 46: Germany Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2015-2025F
  • Figure 47: Germany Peripheral Blood Mononuclear Cells Market Share, By Technique, By Value, 2015-2025F
  • Figure 48: Germany Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2015-2025F
  • Figure 49: France Peripheral Blood Mononuclear Cells Market Size, By Value, 2015-2025F (USD Million)
  • Figure 50: France Healthcare Spending, By Value (USD Per Capita), 2015-2019
  • Figure 51: France Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2015-2025F
  • Figure 52: France Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2015-2025F
  • Figure 53: France Peripheral Blood Mononuclear Cells Market Share, By Technique, By Value, 2015-2025F
  • Figure 54: France Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2015-2025F
  • Figure 55: United Kingdom Peripheral Blood Mononuclear Cells Market Size, By Value, 2015-2025F (USD Million)
  • Figure 56: New Cancer Cases in United Kingdom, (%), 2019
  • Figure 57: United Kingdom Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2015-2025F
  • Figure 58: United Kingdom Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2015-2025F
  • Figure 59: United Kingdom Peripheral Blood Mononuclear Cells Market Share, By Technique, By Value, 2015-2025F
  • Figure 60: United Kingdom Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2015-2025F
  • Figure 61: Italy Peripheral Blood Mononuclear Cells Market Size, By Value, 2015-2025F (USD Million)
  • Figure 62: Italy Total Health Expenditure as a Share of GDP (%), 2015 - 2019
  • Figure 63: Italy Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2015-2025F
  • Figure 64: Italy Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2015-2025F
  • Figure 65: Italy Peripheral Blood Mononuclear Cells Market Share, By Technique, By Value, 2015-2025F
  • Figure 66: Italy Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2015-2025F
  • Figure 67: Asia-Pacific Peripheral Blood Mononuclear Cells Market Size, By Value, 2015-2025F (USD Million)
  • Figure 68: Asia-Pacific Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2015-2025F
  • Figure 69: Asia-Pacific Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2015-2025F
  • Figure 70: Asia-Pacific Peripheral Blood Mononuclear Cells Market Share, By Technique, By Value, 2015-2025F
  • Figure 71: Asia-Pacific Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2015-2025F
  • Figure 72: Asia-Pacific Peripheral Blood Mononuclear Cells Market Size, By Country, 2015-2025F
  • Figure 73: China Peripheral Blood Mononuclear Cells Market Size, By Value, 2015-2025F (USD Million)
  • Figure 74: New Cancer Cases in China (%), 2019
  • Figure 75: China Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2015-2025F
  • Figure 76: China Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2015-2025F
  • Figure 77: China Peripheral Blood Mononuclear Cells Market Share, By Technique, By Value, 2015-2025F
  • Figure 78: China Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2015-2025F
  • Figure 79: Japan Peripheral Blood Mononuclear Cells Market Size, By Value, 2015-2025F (USD Million)
  • Figure 80: Japan Total Health Expenditure as a Share of GDP (%), 2015 - 2019
  • Figure 81: Japan Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2015-2025F
  • Figure 82: Japan Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2015-2025F
  • Figure 83: Japan Peripheral Blood Mononuclear Cells Market Share, By Technique, By Value, 2015-2025F
  • Figure 84: Japan Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2015-2025F
  • Figure 85: India Peripheral Blood Mononuclear Cells Market Size, By Value, 2015-2025F (USD Million)
  • Figure 86: Total Number of Hospitals in India, 2019
  • Figure 87: India Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2015-2025F
  • Figure 88: India Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2015-2025F
  • Figure 89: India Peripheral Blood Mononuclear Cells Market Share, By Technique, By Value, 2015-2025F
  • Figure 90: India Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2015-2025F
  • Figure 91: South Korea Peripheral Blood Mononuclear Cells Market Size, By Value, 2015-2025F (USD Million)
  • Figure 92: New Cancer Cases in South Korea (%), 2019
  • Figure 93: South Korea Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2015-2025F
  • Figure 94: South Korea Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2015-2025F
  • Figure 95: South Korea Peripheral Blood Mononuclear Cells Market Share, By Technique, By Value, 2015-2025F
  • Figure 96: South Korea Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2015-2025F
  • Figure 97: Australia Peripheral Blood Mononuclear Cells Market Size, By Value, 2015-2025F (USD Million)
  • Figure 98: % of Public and Private Hospitals in Australia, 2019
  • Figure 99: Australia Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2015-2025F
  • Figure 100: Australia Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2015-2025F
  • Figure 101: Australia Peripheral Blood Mononuclear Cells Market Share, By Technique, By Value, 2015-2025F
  • Figure 102: Australia Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2015-2025F
  • Figure 103: Singapore Peripheral Blood Mononuclear Cells Market Size, By Value, 2015-2025F (USD Million)
  • Figure 104: New Cancer Cases in Singapore (%), 2019
  • Figure 105: Singapore Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2015-2025F
  • Figure 106: Singapore Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2015-2025F
  • Figure 107: Singapore Peripheral Blood Mononuclear Cells Market Share, By Technique, By Value, 2015-2025F
  • Figure 108: Singapore Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2015-2025F
  • Figure 109: South America Peripheral Blood Mononuclear Cells Market Size, By Value, 2015-2025F (USD Million)
  • Figure 110: South America Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2015-2025F
  • Figure 111: South America Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2015-2025F
  • Figure 112: South America Peripheral Blood Mononuclear Cells Market Share, By Technique, By Value, 2015-2025F
  • Figure 113: South America Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2015-2025F
  • Figure 114: South America Peripheral Blood Mononuclear Cells Market Size, By Country, 2015-2025F
  • Figure 115: Brazil Peripheral Blood Mononuclear Cells Market Size, By Value, 2015-2025F (USD Million)
  • Figure 116: Total Number of Hospitals in Brazil, 2015-2019s
  • Figure 117: Brazil Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2015-2025F
  • Figure 118: Brazil Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2015-2025F
  • Figure 119: Brazil Peripheral Blood Mononuclear Cells Market Share, By Technique, By Value, 2015-2025F
  • Figure 120: Brazil Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2015-2025F
  • Figure 121: Argentina Peripheral Blood Mononuclear Cells Market Size, By Value, 2015-2025F (USD Million)
  • Figure 122: Argentina Health Expenditure (% of GDP), 2015-2019
  • Figure 123: Argentina Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2015-2025F
  • Figure 124: Argentina Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2015-2025F
  • Figure 125: Argentina Peripheral Blood Mononuclear Cells Market Share, By Technique, By Value, 2015-2025F
  • Figure 126: Argentina Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2015-2025F
  • Figure 127: Colombia Peripheral Blood Mononuclear Cells Market Size, By Value, 2015-2025F (USD Million)
  • Figure 128: New Cancer Cases in Colombia (%), 2019
  • Figure 129: Colombia Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2015-2025F
  • Figure 130: Colombia Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2015-2025F
  • Figure 131: Colombia Peripheral Blood Mononuclear Cells Market Share, By Technique, By Value, 2015-2025F
  • Figure 132: Colombia Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2015-2025F
  • Figure 133: Middle East & Africa Peripheral Blood Mononuclear Cells Market Size, By Value, 2015-2025F (USD Million)
  • Figure 134: Middle East & Africa Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2015-2025F
  • Figure 135: Middle East & Africa Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2015-2025F
  • Figure 136: Middle East & Africa Peripheral Blood Mononuclear Cells Market Share, By Technique, By Value, 2015-2025F
  • Figure 137: Middle East & Africa Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2015-2025F
  • Figure 138: Middle East and Africa Peripheral Blood Mononuclear Cells Market Size, By Country, 2015-2025F
  • Figure 139: UAE Peripheral Blood Mononuclear Cells Market Size, By Value, 2015-2025F (USD Million)
  • Figure 140: UAE Health Expenditure (% of GDP), 2015-2019
  • Figure 141: UAE Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2015-2025F
  • Figure 142: UAE Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2015-2025F
  • Figure 143: UAE Peripheral Blood Mononuclear Cells Market Share, By Technique, By Value, 2015-2025F
  • Figure 144: UAE Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2015-2025F
  • Figure 145: Saudi Arabia Peripheral Blood Mononuclear Cells Market Size, By Value, 2015-2025F (USD Million)
  • Figure 146: Total Number of Hospitals in Saudi Arabia, 2015-2019
  • Figure 147: Saudi Arabia Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2015-2025F
  • Figure 148: Saudi Arabia Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2015-2025F
  • Figure 149: Saudi Arabia Peripheral Blood Mononuclear Cells Market Share, By Technique, By Value, 2015-2025F
  • Figure 150: Saudi Arabia Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2015-2025F
  • Figure 151: South Africa Peripheral Blood Mononuclear Cells Market Size, By Value, 2015-2025F (USD Million)
  • Figure 152: South Africa Healthcare Spending, By Value, 2015 -2019 (USD Per Capita)
  • Figure 153: South Africa Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2015-2025F
  • Figure 154: South Africa Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2015-2025F
  • Figure 155: South Africa Peripheral Blood Mononuclear Cells Market Share, By Technique, By Value, 2015-2025F
  • Figure 156: South Africa Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2015-2025F
目次
Product Code: 4561

Title:
Global Peripheral Blood Mononuclear Cells Market, By Product (Cryopreserved or Frozen PBMC, Cultured or Fresh PBMC, Peripheral Blood Mononuclear Cell Isolation & Viability Kits), By Application (Immunology, Infectious Disease, Hematology and Others), By Technique (Density Gradient Centrifugation Process, Leukapheresis), By Source (Human, Animals), By Region, Competition, Forecast & Opportunities, 2025.

The global market for peripheral blood mononuclear cells (PBMC) was valued at USD 172.29 Million in 2019 and is projected to grow at a CAGR of 8.46% during 2020 - 2025. The PBMC are crucial to carry out the biology and pathology related studies as well as in clinical research. Besides, PBMCs are also utilized in research related to fatal diseases, immunology, vaccine development, etc. However, high cost of PBMCs related studies might act as a challenge for the adoption of technology, especially in developing economies.

The global peripheral blood mononuclear cells market is segmented based on product, application, technique, source, and region. The product segment is further divided into cryopreserved or frozen PBMC, cultured or fresh PBMC and peripheral blood mononuclear cell isolation & viability kits. As of 2019, the cryopreserved PBMC or the frozen PBMC segment held the dominant market share as they can be used for longer durations of time if stored carefully at lower temperatures.

Based on regional analysis, North America accounted for the largest market share in the year 2019, on the back of a number of pre-existing peripheral blood mononuclear cells-based companies in the region. The economy of the region is also rich enough, which makes it easier to carry out the complex and costly R&D procedures.

Major players operating in the global peripheral blood mononuclear cells market include Thermo Fisher Scientific Inc., Merck & Co., Inc., Corning Incorporate, Bio-Rad Laboratories, Inc., Cellero, LLC, Life Technologies (India) Pvt. Ltd., Cell Applications, Inc., DAPCEL, Inc., Creative Bioarray, iXCells Biotechnologies USA, LLC, Miltenyi Biotec B.V. & CO. KG, STEMCELL Technologies Inc., Precision Medicine Group, LLC., StemExpress, LLC, HemaCare Corporation, BioVision, Inc., BioLegend, Inc., BioIVT LLC, Biopredic International, Zen-Bio Inc., etc.

Years considered for this report:

  • Historical Years: 2015 - 2018
  • Base Year: 2019
  • Estimated Year: 2020
  • Forecast Period: 2021 - 2025

Objective of the Study:

  • To analyze and forecast the market size of global peripheral blood mononuclear cells market.
  • To classify and forecast global peripheral blood mononuclear cells market based on product, application, technique, source, and region.
  • To identify drivers and challenges for global peripheral blood mononuclear cells market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global peripheral blood mononuclear cells market.
  • To conduct pricing analysis for global peripheral blood mononuclear cells market.
  • To identify and analyze the profile of leading players operating in global peripheral blood mononuclear cells market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of leading market players across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the research organizations and companies which could not be identified due to the limitations of secondary research. TechSci Research analyzed the research organizations and companies, and presence of all major players across the globe.

TechSci Research calculated the market size of global peripheral blood mononuclear cells market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Biotechnology and pharma companies and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to peripheral blood mononuclear cells
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as research organizations & companies and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global peripheral blood mononuclear cells market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Market, By Product:

  • Cryopreserved or Frozen PBMC
  • Cultured or Fresh PBMC
  • Peripheral Blood Mononuclear Cell Isolation & Viability Kits

Market, By Application:

  • Immunology
  • Infectious disease
  • Hematology
  • Others

Market, By Technique:

  • Density gradient centrifugation process
  • Leukapheresis

Market, By Source:

  • Human
  • Animals

Market, By Region:

  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Singapore
    • Australia
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
  • North America
    • United States
    • Mexico
    • Canada
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle east & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global peripheral blood mononuclear cells market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Peripheral Blood Mononuclear Cells Market

4. Executive Summary

5. Voice of Customer

  • 5.1. By Type of Product
  • 5.2. By Type of Technique
  • 5.3. Type of Application for Which PBMCs Are Used
  • 5.4. Factors Driving Market Growth

6. Global Peripheral Blood Mononuclear Cells Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product (Cryopreserved or Frozen PBMC, Cultured or Fresh PBMC, Peripheral Blood Mononuclear Cell Isolation & Viability Kits)
    • 6.2.2. By Application (Immunology, Infectious disease, Hematology and others)
    • 6.2.3. By Technique (Density gradient centrifugation process, Leukapheresis)
    • 6.2.4. By Source (Human, Animals)
    • 6.2.5. By Company (2019)
    • 6.2.6. By Region
  • 6.3. Product Market Map

7. Asia-Pacific Peripheral Blood Mononuclear Cells Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Application
    • 7.2.3. By Technique
    • 7.2.4. By Source
    • 7.2.5. By Country
  • 7.3. Asia-Pacific: Country Analysis
    • 7.3.1. China Peripheral Blood Mononuclear Cells Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By Technique
        • 7.3.1.2.4. By Source
    • 7.3.2. India Peripheral Blood Mononuclear Cells Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By Technique
        • 7.3.2.2.4. By Source
    • 7.3.3. Japan Peripheral Blood Mononuclear Cells Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By Technique
        • 7.3.3.2.4. By Source
    • 7.3.4. South Korea Peripheral Blood Mononuclear Cells Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By Technique
        • 7.3.4.2.4. By Source
    • 7.3.5. Singapore Peripheral Blood Mononuclear Cells Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By Technique
        • 7.3.5.2.4. By Source
    • 7.3.6. Australia Peripheral Blood Mononuclear Cells Market Outlook
      • 7.3.6.1. Market Size & Forecast
        • 7.3.6.1.1. By Value
      • 7.3.6.2. Market Share & Forecast
        • 7.3.6.2.1. By Product
        • 7.3.6.2.2. By Application
        • 7.3.6.2.3. By Technique
        • 7.3.6.2.4. By Source

8. Europe Peripheral Blood Mononuclear Cells Market Outlook

  • 8.1. Market Size & Forecast
  • 8.2. Market Size & Forecast
    • 8.2.1. By Value
  • 8.3. Market Share & Forecast
    • 8.3.1. By Product
    • 8.3.2. By Application
    • 8.3.3. By Technique
    • 8.3.4. By Source
    • 8.3.5. By Country
  • 8.4. Europe: Country Analysis
    • 8.4.1. France Peripheral Blood Mononuclear Cells Market Outlook
      • 8.4.1.1. Market Size & Forecast
        • 8.4.1.1.1. By Value
      • 8.4.1.2. Market Share & Forecast
        • 8.4.1.2.1. By Product
        • 8.4.1.2.2. By Application
        • 8.4.1.2.3. By Technique
        • 8.4.1.2.4. By Source
    • 8.4.2. Germany Peripheral Blood Mononuclear Cells Market Outlook
      • 8.4.2.1. Market Size & Forecast
        • 8.4.2.1.1. By Value
      • 8.4.2.2. Market Share & Forecast
        • 8.4.2.2.1. By Product
        • 8.4.2.2.2. By Application
        • 8.4.2.2.3. By Technique
        • 8.4.2.2.4. By Source
    • 8.4.3. United Kingdom Peripheral Blood Mononuclear Cells Market Outlook
      • 8.4.3.1. Market Size & Forecast
        • 8.4.3.1.1. By Value
      • 8.4.3.2. Market Share & Forecast
        • 8.4.3.2.1. By Product
        • 8.4.3.2.2. By Application
        • 8.4.3.2.3. By Technique
        • 8.4.3.2.4. By Source
    • 8.4.4. Italy Peripheral Blood Mononuclear Cells Market Outlook
      • 8.4.4.1. Market Size & Forecast
        • 8.4.4.1.1. By Value
      • 8.4.4.2. Market Share & Forecast
        • 8.4.4.2.1. By Product
        • 8.4.4.2.2. By Application
        • 8.4.4.2.3. By Technique
        • 8.4.4.2.4. By Source

9. North America Peripheral Blood Mononuclear Cells Market Outlook

  • 9.1. Market Size & Forecast
  • 9.2. Market Size & Forecast
    • 9.2.1. By Value
  • 9.3. Market Share & Forecast
    • 9.3.1. By Product
    • 9.3.2. By Application
    • 9.3.3. By Technique
    • 9.3.4. By Source
    • 9.3.5. By Country
  • 9.4. North America: Country Analysis
    • 9.4.1. United States Peripheral Blood Mononuclear Cells Market Outlook
      • 9.4.1.1. Market Size & Forecast
        • 9.4.1.1.1. By Value
      • 9.4.1.2. Market Share & Forecast
        • 9.4.1.2.1. By Product
        • 9.4.1.2.2. By Application
        • 9.4.1.2.3. By Technique
        • 9.4.1.2.4. By Source
    • 9.4.2. Mexico Peripheral Blood Mononuclear Cells Market Outlook
      • 9.4.2.1. Market Size & Forecast
        • 9.4.2.1.1. By Value
      • 9.4.2.2. Market Share & Forecast
        • 9.4.2.2.1. By Product
        • 9.4.2.2.2. By Application
        • 9.4.2.2.3. By Technique
        • 9.4.2.2.4. By Source
    • 9.4.3. Canada Peripheral Blood Mononuclear Cells Market Outlook
      • 9.4.3.1. Market Size & Forecast
        • 9.4.3.1.1. By Value
      • 9.4.3.2. Market Share & Forecast
        • 9.4.3.2.1. By Product
        • 9.4.3.2.2. By Application
        • 9.4.3.2.3. By Technique
        • 9.4.3.2.4. By Source

10. South America Peripheral Blood Mononuclear Cells Market Outlook

  • 10.1. Market Size & Forecast
  • 10.2. Market Size & Forecast
    • 10.2.1. By Value
  • 10.3. Market Share & Forecast
    • 10.3.1. By Product
    • 10.3.2. By Application
    • 10.3.3. By Technique
    • 10.3.4. By Source
    • 10.3.5. By Country
  • 10.4. South America: Country Analysis
    • 10.4.1. Brazil Peripheral Blood Mononuclear Cells Market Outlook
      • 10.4.1.1. Market Size & Forecast
        • 10.4.1.1.1. By Value
      • 10.4.1.2. Market Share & Forecast
        • 10.4.1.2.1. By Product
        • 10.4.1.2.2. By Application
        • 10.4.1.2.3. By Technique
        • 10.4.1.2.4. By Source
    • 10.4.2. Argentina Peripheral Blood Mononuclear Cells Market Outlook
      • 10.4.2.1. Market Size & Forecast
        • 10.4.2.1.1. By Value
      • 10.4.2.2. Market Share & Forecast
        • 10.4.2.2.1. By Product
        • 10.4.2.2.2. By Application
        • 10.4.2.2.3. By Technique
        • 10.4.2.2.4. By Source
    • 10.4.3. Colombia Peripheral Blood Mononuclear Cells Market Outlook
      • 10.4.3.1. Market Size & Forecast
        • 10.4.3.1.1. By Value
      • 10.4.3.2. Market Share & Forecast
        • 10.4.3.2.1. By Product
        • 10.4.3.2.2. By Application
        • 10.4.3.2.3. By Technique
        • 10.4.3.2.4. By Source

11. Middle East and Africa Peripheral Blood Mononuclear Cells Market Outlook

  • 11.1. Market Size & Forecast
  • 11.2. Market Size & Forecast
    • 11.2.1. By Value
  • 11.3. Market Share & Forecast
    • 11.3.1. By Product
    • 11.3.2. By Application
    • 11.3.3. By Technique
    • 11.3.4. By Source
    • 11.3.5. By Country
  • 11.4. MEA: Country Analysis
    • 11.4.1. South Africa Peripheral Blood Mononuclear Cells Market Outlook
      • 11.4.1.1. Market Size & Forecast
        • 11.4.1.1.1. By Value
      • 11.4.1.2. Market Share & Forecast
        • 11.4.1.2.1. By Product
        • 11.4.1.2.2. By Application
        • 11.4.1.2.3. By Technique
        • 11.4.1.2.4. By Source
    • 11.4.2. Saudi Arabia Peripheral Blood Mononuclear Cells Market Outlook
      • 11.4.2.1. Market Size & Forecast
        • 11.4.2.1.1. By Value
      • 11.4.2.2. Market Share & Forecast
        • 11.4.2.2.1. By Product
        • 11.4.2.2.2. By Application
        • 11.4.2.2.3. By Technique
        • 11.4.2.2.4. By Source
    • 11.4.3. UAE Peripheral Blood Mononuclear Cells Market Outlook
      • 11.4.3.1. Market Size & Forecast
        • 11.4.3.1.1. By Value
      • 11.4.3.2. Market Share & Forecast
        • 11.4.3.2.1. By Product
        • 11.4.3.2.2. By Application
        • 11.4.3.2.3. By Technique
        • 11.4.3.2.4. By Source

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Clinical Trials

15. Competitive Landscape

  • 15.1. Competition Outlook
  • 15.2. Players Profiled (Leading Companies)
    • 15.2.1. Thermo Fisher Scientific Inc.
    • 15.2.2. Merck & Co., Inc.
    • 15.2.3. Corning Incorporate
    • 15.2.4. Bio-Rad Laboratories, Inc.
    • 15.2.5. Cellero, LLC
    • 15.2.6. Life Technologies (India) Pvt. Ltd.
    • 15.2.7. Cell Applications, Inc.
    • 15.2.8. DAPCEL, Inc.
    • 15.2.9. Creative Bioarray
    • 15.2.10. iXCells Biotechnologies USA, LLC
    • 15.2.11. Miltenyi Biotec B.V. & CO. KG
    • 15.2.12. STEMCELL Technologies Inc.
    • 15.2.13. Precision Medicine Group, LLC.
    • 15.2.14. StemExpress, LLC
    • 15.2.15. HemaCare Corporation
    • 15.2.16. BioVision, Inc.
    • 15.2.17. BioLegend, Inc.
    • 15.2.18. BioIVT LLC
    • 15.2.19. Biopredic International
    • 15.2.20. Zen-Bio Inc.

16. Strategic Recommendation

17. About Us & Disclaimer